Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa

References

• FimmelSZoumboulisCCComordidities of hidradenitis suppurativa (acne inversa)Dermatoendocrinol2010291621547142
   PubMedGoogle Scholar
• ZoumboulisCCDessaiNEmtestamLEuropean S1 guideline for the treatment of hidradenitis supppurativa/acne inversaJ Eur Acad Dermatol Venereol20152961964425640693
   PubMed Web of Science ®Google Scholar
• MartorellAGarcia-MartinezFJJimenez-GalloDAn update on hidradenitis suppurativa (part I): epidemiology, clinical aspects and definition of disease severityActas Dermosifiliogr201510670371526254550
   PubMed Web of Science ®Google Scholar
• JemecGBKimbalABEpidemiology and scope of the problemJ Am Acad Dermatol201573S4S726470614
   PubMed Web of Science ®Google Scholar
• RevuzJECanoui-PoitrineFWolksteinRPrevalence and factors associated with hidradenitis suppurativa: results from two case controls studiesJ Am Acad Dermatol20085959660118674845
   PubMed Web of Science ®Google Scholar
• JemecGBHeidenheimMNielsenNHThe prevalence of hidradenitis suppurativa and its potential precursor lesionsJ Am Acad Dermatol1996351911948708018
   PubMed Web of Science ®Google Scholar
• VazquezBGAlikhanAWeaverALWetterDADavisMDIncidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted county, MinnesotaJ Invest Dermatol20131339710322931916
   PubMed Web of Science ®Google Scholar
• Cannoui–PoitrineFRevuzJEWolkensteinPClinical charecterisitcs of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severityJ Am Acad Dermatol200961515719406505
   PubMed Web of Science ®Google Scholar
• MichellettiRGNatural history, presentation and diagnosis of hidradenitis suppurativaSemin Cutan Med Surg201433Suppl 3S51S5325188458
   PubMed Web of Science ®Google Scholar
• MatusiakLBienekASzepietowskiJCHidradenitis Supurativa and associated factors: still unsolved problemsJ Am Acad Dermatol20096136236519615551
   PubMed Web of Science ®Google Scholar
• PrensEDeckersIPathophysiology of hidradenitis suppurativa: an updateJ Am Acad Dermatol201573S8S1126470623
   PubMed Web of Science ®Google Scholar
• BarlevDEisenDBAlikhanAHidradenitis suppurativa a review with a focus on treatment dataSkin Therapy Lett20152018
   Google Scholar
• KellyGSweeneySMTobinAMKirbyBHidradenitis suppurativa: the role of immune dysregulationInt J Dermatol2014531186119624961484
   PubMed Web of Science ®Google Scholar
• DrenoBKhammariABrockardAHidradenitis supurativa: the role of deficient cutaneous innate immunityArch Dermatol201214818218622004878
   PubMedGoogle Scholar
• WangBYangWWenWGamma-secretase gene mutations in familial acne inversaScience2010330106520929727
   PubMed Web of Science ®Google Scholar
• AlikhanALynchPJEisenDBHidradenitis Suppurativa: a comprehensive reviewJ Am Acad Dermatol20096053956119293006
   PubMed Web of Science ®Google Scholar
• DeckersIEvan der ZeeHHPrensEPEpidemiology of hidradenitis suppurativa: prevalence, pathogenesis, and factors associated with the development of HSCurr Dermatol Rep201435460
   Google Scholar
• KonigALehmannCRompelRHappleRCigarette smoking as a triggering factor of hidradenitis suppurativaDermatology199919826126410393449
   PubMed Web of Science ®Google Scholar
• SartoriusKEmtestamLJemecGBLapinsJObjective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesityBr J Dermatol200916183183919438453
   PubMed Web of Science ®Google Scholar
• MargessonLJDanbyFWHidradenitis suppurativaBest Pract Res Clin Obstet Gynaecol2014281013102725214437
   PubMed Web of Science ®Google Scholar
• MichelletiRGHidradenitis suppurativa: current views on epidemiology, pathogenesis and pathophysiologySemin Cutan Med Surg201433Suppl 3S48S5025188457
   PubMed Web of Science ®Google Scholar
• Van der ZeeHHde RuiterLBoerJvan de BroeckeDGAlterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesionsBr J Dermatol20121669810621929531
   PubMed Web of Science ®Google Scholar
• KathjuSLaskoLAStoodleyPConsidering hidradenitis suppurativa as a bacterial biofilm diseaseFEMS Immunol Med Microbiol20126538538922353357
   PubMedGoogle Scholar
• ScheinfieldNDiseases associated with hidradenitis suppurativa: Part 2 of a series on hidradenitisDermatol Online J2013191855824011308
   PubMedGoogle Scholar
• Van der ZeeHHvan der WoudeCJFlorenciaEFPrensEPHidradenitis suppurativa and inflammatory bowel disease: are they associated? Results from a pilot studyBr J Dermatol201016219519719681876
   PubMed Web of Science ®Google Scholar
• RichettePMoltoAViguierMHidradenitis suppurativa associated with spondyloarthritis-results from a multicenter national prospective studyJ Rheumatol20145311861196
   Google Scholar
• GooderhamMPappKThe psychological impact of hidradenitis suppurativaJ Am Acad Dermatol201573S19S2226470609
   PubMed Web of Science ®Google Scholar
• von de WerthJMJemecGBMorbidity in patients with hidradenitis supurativaBr J Dermatol200114480981311298541
   PubMed Web of Science ®Google Scholar
• OnderdijkAJvan der ZeeHHEsmannSDepression in patients with hidradenitis suppurativaJ Eur Acad Dermatol Venereol20132747347822339940
   PubMed Web of Science ®Google Scholar
• MatusiakLBieniekKSzepietowskiJCPsycophysical aspects of hidradenitis suppurativaActa Dermatol Venereol201090264268
   PubMed Web of Science ®Google Scholar
• GulliverWZouboulisCPrensEJemrcGBTzellosTEvidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativaRev Endocr Metab Disord Epub201621
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyHumira^® Summary of product characteristics [WWW document]2009 [updated 26 May 2016]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000481/WC500050870.pdfAccessed June 13, 2016
   Google Scholar
• HanauerSBFeaganBGLichtensteinGRMaintenance inflix-imab for Crohn’s disease: the ACCENT 1 randomised trialLancet200235915421549
   Web of Science ®Google Scholar
• HaslundPLeeRJemecGBTreatment of hidradenitis suppurativa with anti-tumor necrosis factor-α inhibitorsActa Derm Venereol20098959560019997689
   PubMed Web of Science ®Google Scholar
• MatusiakLBieniekKSzepietowskiJCIncreased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?Acta Derma Venereol (Stockh)200989601603
   PubMed Web of Science ®Google Scholar
• van der ZeeHHde RuiterIvan de BroeckeDGDikWALamanJDPrensEPElevated levels of tumour necrosis factor (TNF)-a, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1βBr J Dermatol20111641292129821332464
   PubMed Web of Science ®Google Scholar
• van der ZeeHHLamanJDde RuiterLDikWAPrensEPAdalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo studyBr J Dermatol201216629830522013960
   PubMed Web of Science ®Google Scholar
• SotiriouEApallaZVakirlisEIoannidesDEfficacy of adalimumab in recalcitrant hidradenitis suppurativaEur J Dermatol20091918018119153066
   PubMed Web of Science ®Google Scholar
• YamauchiPSMauNHidradenitis suppurativa managed with adalimumabJ Drugs Dermatol2009818118319213236
   PubMed Web of Science ®Google Scholar
• ArenbergerovaMGkalpakiotisSArenbergerPEffective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapyInt J Dermatol2010491445144921091684
   PubMed Web of Science ®Google Scholar
• BlancoRMartinez–TaboadaVMVillaLLong-term successful adalimumab therapy for hidradenitis suppurativaArch Dermatol200914558058419451504
   PubMed Web of Science ®Google Scholar
• AmanoMGrantAKerdelFAA prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativaInt J Dermatol20104995095521128923
   PubMed Web of Science ®Google Scholar
• SotiriouEGoussiCLallasAA prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativaJ Drugs Dermatol201211s15s2022644772
   PubMed Web of Science ®Google Scholar
• MillerILynggaardCDZachariaeCDufourDNJemecGBA double blind placebo controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativaBr J Dermatol201116539139821457202
   PubMed Web of Science ®Google Scholar
• KimbalAKerdelFAdamsDAdalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trialAnn Intern Med201215784685523247938
   PubMed Web of Science ®Google Scholar
• KimbalAZouboulisCArmstrongASafety and efficacy of adalimumab in patients with severe hidradenitis suppurativa: results from PIONEER I, a phase 3 randomized, placebo-controlled trialJ Am Acad Dermatol201572S1 AB60, P: 50725500024
   PubMed Web of Science ®Google Scholar
• JemecGBGottliebAGiamarellos-BourboulisEReguiaiZGuYOkunMSafety and efficacy of adalimumab in patients with severe hidradenitis suppurativa: results from PIONEER II, a phase 3 randomized, placebo-controlled trialJ Am Acad Dermatol201572S1 AB45, P: 63125500024
   PubMed Web of Science ®Google Scholar
• ArmstrongAPinskyBSundaramMOkunMBaoYAdalimumab improves health related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): results from the first weeks of PIONEER IIPresented at the 23rd Annual meeting of the American Academy of DermatologyMarch 20–24, 2015San Fransisco, California
   Google Scholar
• LeeREisenDTreatment of hidradenitis suppurativa with biologic medicationsJ Am Acad Dermatol201573S82826470624
   PubMed Web of Science ®Google Scholar
• MortiaryBJiyadZCreamerDFour-weekly infliximab in the treatment of severe hidradenitis suppurativaBr J Dermatol201417098698724641123
   PubMed Web of Science ®Google Scholar
• GrantAGonzalezTMontgomeryMOCardenasVKerdelFAInfliximab therapy for patients with moderate hidradenitis suppurativa: a randomized, double-blind, placebo controlled crossover trialJ Am Acad Dermatol20106220521720115947
   PubMed Web of Science ®Google Scholar
• SbidianEHotzCSeneschalJAntitumour necrosis factor–α for hidradenitis suppurativa: results from a national cohort study between 200 and 2003Br J Dermatol201617466767026406350
   PubMed Web of Science ®Google Scholar
• SotiriouEApallaZIoannidesDEtanercept for the treatment of hidradenitis suppurativaActa Derm Venereol200989828319197548
   PubMed Web of Science ®Google Scholar
• Giamarellos-BourboulisEIPelekanouEAntonopoulouAAn open label phase II study on the safety and efficacy of etanercept for the therapy of hidradentis suppurativaBr J Dermatol200815856757218076705
   PubMed Web of Science ®Google Scholar
• AdamsDRYankuraIAFogelbergACAndersonBETreatment of hidradenitis suppurativa with etanercept injectionArch Dermatol201014650150420479297
   PubMed Web of Science ®Google Scholar
• GulliverWPJemecGBBakerKAExperience with ustekinumab for the treatment of moderate to severe hidradenitis suppuratiavJ Eur Acad Dermatol Venereol20122691191421605174
   PubMed Web of Science ®Google Scholar
• RussoVAlikhanAFailure of Anakinra in a case of severe hidradenitis suppurativaJ Drugs Dermatol20161577277427272089
   PubMed Web of Science ®Google Scholar
• MenisDMaroñas-JiménezLDelgado-MarquezAMPostigo-LlorenteCVanaclocha-SebastiánFTwo cases of severe hidradenitis suppurativa with failure of anakinra therapyBr J Dermatol201517281081125059730
   PubMed Web of Science ®Google Scholar
• ZarchiKDufourDNJemecGBSuccessful treatment of severe hidradenitis suppurativa with anakinraJAMA Dermatol20131491192119423966107
   PubMed Web of Science ®Google Scholar
• LeslieKSTripathiSVNguyenTVPauliMRosenblumMDAn open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativaJ Am Acad Dermatol20147024325124314876
   PubMed Web of Science ®Google Scholar
• TzanetakouVKanniTGiatrakouSSafety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trialJAMA Dermatol2016152525926579854
   PubMed Web of Science ®Google Scholar